{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:29:17Z","timestamp":1785803357955,"version":"3.56.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-023-00988-2","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T17:01:41Z","timestamp":1695315701000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of \u03b1-synuclein"],"prefix":"10.1007","volume":"37","author":[{"given":"Farideh","family":"Iravanpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid Reza","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-448X","authenticated-orcid":false,"given":"Morteza","family":"Jafarinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh Tavakoli","family":"Oliaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"3","key":"988_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12026-022-09268-x","volume":"70","author":"S Fattahi","year":"2022","unstructured":"Fattahi S, Khalifehzadeh-Esfahani Z, Mohammad-Rezaei M, Mafi S, Jafarinia M. PI3K\/Akt\/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy. Immunol Res. 2022;70(3):269\u201375.","journal-title":"Immunol Res"},{"issue":"1","key":"988_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/bbrj.bbrj_280_21","volume":"6","author":"K Garg","year":"2022","unstructured":"Garg K, Talwar D, Mahajan SN, Karim S, Prajapati K, Patel S, et al. A review on COVID-19 vaccinations. Biomed Biotechnol Res J (BBRJ). 2022;6(1):50\u20133.","journal-title":"Biomed Biotechnol Res J (BBRJ)."},{"issue":"2","key":"988_CR3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/ijmy.ijmy_51_21","volume":"10","author":"S Patil","year":"2021","unstructured":"Patil S, Gondhali G. COVID-19 pneumonia with pulmonary tuberculosis: double trouble. Int J Mycobacteriol. 2021;10(2):206\u20139.","journal-title":"Int J Mycobacteriol."},{"issue":"6483","key":"988_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260\u20133. https:\/\/doi.org\/10.1126\/science.abb2507.","journal-title":"Science"},{"issue":"7798","key":"988_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7.","journal-title":"Nature"},{"key":"988_CR6","doi-asserted-by":"crossref","unstructured":"Jamali E, Shapoori S, Farrokhi MR, Vakili S, Rostamzadeh D, Iravanpour F et al. Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review. Viral Immunol. 2023.","DOI":"10.1089\/vim.2023.0035"},{"key":"988_CR7","doi-asserted-by":"crossref","unstructured":"Verma T, Sinha M, Nitin B, Yadav S, Shah K, Chauhan N. A review on Coronavirus Disease and potentially active drugs targeting Coronavirus. Biomed Biotechnol Res J. 2021;5(2):110-.","DOI":"10.4103\/bbrj.bbrj_14_21"},{"issue":"1","key":"988_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/bbrj.bbrj_229_21","volume":"6","author":"M Faheem","year":"2022","unstructured":"Faheem M, Singh VK, Srivastava A. Recent insights of SARS-CoV-2 potential inhibitors. Biomed Biotechnol Res J (BBRJ). 2022;6(1):21\u201332.","journal-title":"Biomed Biotechnol Res J (BBRJ)."},{"issue":"1","key":"988_CR9","doi-asserted-by":"publisher","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","volume":"292","author":"MF Doobay","year":"2007","unstructured":"Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R373\u201381. https:\/\/doi.org\/10.1152\/ajpregu.00292.2006.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"988_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/bbrj.bbrj_166_20","volume":"5","author":"S Quazi","year":"2021","unstructured":"Quazi S. Vaccine in response to COVID-19: Recent developments, challenges, and a way out. Biomed Biotechnol Res J. 2021;5(2):105.","journal-title":"Biomed Biotechnol Res J."},{"issue":"3","key":"988_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000529927","volume":"86","author":"MR Farrokhi","year":"2023","unstructured":"Farrokhi MR, Iravanpour F, Nejabat N. Development of acute transverse myelitis following COVID-19 infection: a review on the potential pathways. Eur Neurol. 2023;86(3):209\u201316. https:\/\/doi.org\/10.1159\/000529927.","journal-title":"Eur Neurol"},{"key":"988_CR12","doi-asserted-by":"publisher","unstructured":"Rahmati M, Yon DK, Lee SW, Soysal P, Koyanagi A, Jacob L et al. New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis. J Med Virol. 2023;95(7):e28909. https:\/\/doi.org\/10.1002\/jmv.28909.","DOI":"10.1002\/jmv.28909"},{"key":"988_CR13","doi-asserted-by":"publisher","unstructured":"Rahmati M, Udeh R, Yon DK, Lee SW, Dolja-Gore X, Mc EM et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J Med Virol. 2023;95(6):e28852. https:\/\/doi.org\/10.1002\/jmv.28852.","DOI":"10.1002\/jmv.28852"},{"issue":"6","key":"988_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/mds.28622","volume":"36","author":"V Leta","year":"2021","unstructured":"Leta V, Rodr\u00edguez-Violante M, Abundes A, Rukavina K, Teo JT, Falup-Pecurariu C, et al. Parkinson\u2019s Disease and Post-COVID-19 Syndrome: The Parkinson\u2019s Long-COVID Spectrum. Mov Disord. 2021;36(6):1287\u20139. https:\/\/doi.org\/10.1002\/mds.28622.","journal-title":"Mov Disord"},{"issue":"2","key":"988_CR15","first-page":"54","volume":"7","author":"A Azhideh","year":"2020","unstructured":"Azhideh A. COVID-19 neurological manifestations. Int Clin Neurosci J. 2020;7(2):54.","journal-title":"Int Clin Neurosci J."},{"key":"988_CR16","doi-asserted-by":"crossref","unstructured":"Farrokhi MR, Iravanpour F, Nejabat N. Development of acute transverse myelitis following COVID-19 infection: a review on the potential pathways. Eur Neurol. 2023:1\u20138.","DOI":"10.1159\/000529927"},{"issue":"Pt B","key":"988_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","volume":"109","author":"NL Rey","year":"2018","unstructured":"Rey NL, Wesson DW, Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis. 2018;109(Pt B):226\u201348. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.013.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"988_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nrl.2015.05.006","volume":"31","author":"A Ben\u00edtez-Burraco","year":"2016","unstructured":"Ben\u00edtez-Burraco A, Herrera E, Cuetos F. A core deficit in Parkinson disease? Neurologia. 2016;31(4):223\u201330. https:\/\/doi.org\/10.1016\/j.nrl.2015.05.006.","journal-title":"Neurologia"},{"issue":"2","key":"988_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.imbio.2015.10.002","volume":"221","author":"A Shameli","year":"2016","unstructured":"Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson HJ, et al. A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology. 2016;221(2):333\u201340. https:\/\/doi.org\/10.1016\/j.imbio.2015.10.002.","journal-title":"Immunobiology"},{"key":"988_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/bs.pmbts.2019.06.002","volume":"168","author":"CT Tulisiak","year":"2019","unstructured":"Tulisiak CT, Mercado G, Peelaerts W, Brundin L, Brundin P. Can infections trigger alpha-synucleinopathies? Prog Mol Biol Transl Sci. 2019;168:299\u2013322. https:\/\/doi.org\/10.1016\/bs.pmbts.2019.06.002.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"2","key":"988_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/s1474-4422(20)30442-7","volume":"20","author":"M Merello","year":"2021","unstructured":"Merello M, Bhatia KP, Obeso JA. SARS-CoV-2 and the risk of Parkinson\u2019s disease: facts and fantasy. Lancet Neurol. 2021;20(2):94\u20135. https:\/\/doi.org\/10.1016\/s1474-4422(20)30442-7.","journal-title":"Lancet Neurol"},{"issue":"10","key":"988_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/s1474-4422(20)30305-7","volume":"19","author":"ME Cohen","year":"2020","unstructured":"Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, et al. A case of probable Parkinson\u2019s disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19(10):804\u20135. https:\/\/doi.org\/10.1016\/s1474-4422(20)30305-7.","journal-title":"Lancet Neurol"},{"issue":"15","key":"988_CR23","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/wnl.0000000000010282","volume":"95","author":"A M\u00e9ndez-Guerrero","year":"2020","unstructured":"M\u00e9ndez-Guerrero A, Laespada-Garc\u00eda MI, G\u00f3mez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020;95(15):e2109\u201318. https:\/\/doi.org\/10.1212\/wnl.0000000000010282.","journal-title":"Neurology"},{"issue":"10","key":"988_CR24","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/mds.28277","volume":"35","author":"I Faber","year":"2020","unstructured":"Faber I, Brand\u00e3o PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus disease 2019 and Parkinsonism: a non-post-encephalitic case. Mov Disord. 2020;35(10):1721\u20132. https:\/\/doi.org\/10.1002\/mds.28277.","journal-title":"Mov Disord"},{"key":"988_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.genhosppsych.2020.05.008","volume":"65","author":"SR Beach","year":"2020","unstructured":"Beach SR, Praschan NC, Hogan C, Dotson S, Merideth F, Kontos N, et al. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. Gen Hosp Psychiatry. 2020;65:47\u201353. https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.05.008.","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"988_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.25783","volume":"88","author":"A Pilotto","year":"2020","unstructured":"Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;88(2):423\u20137. https:\/\/doi.org\/10.1002\/ana.25783.","journal-title":"Ann Neurol"},{"key":"988_CR27","doi-asserted-by":"publisher","unstructured":"Philippens I, B\u00f6sz\u00f6rm\u00e9nyi KP, Wubben JAM, Fagrouch ZC, van Driel N, Mayenburg AQ et al. Brain Inflammation and Intracellular \u03b1-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection. Viruses. 2022;14(4). https:\/\/doi.org\/10.3390\/v14040776.","DOI":"10.3390\/v14040776"},{"issue":"7868","key":"988_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595(7868):565\u201371. https:\/\/doi.org\/10.1038\/s41586-021-03710-0.","journal-title":"Nature"},{"key":"988_CR29","doi-asserted-by":"publisher","unstructured":"K\u00e4ufer C, Schreiber CS, Hartke AS, Denden I, Stanelle-Bertram S, Beck S et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine. 2022;79:103999. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103999.","DOI":"10.1016\/j.ebiom.2022.103999"},{"key":"988_CR30","doi-asserted-by":"publisher","unstructured":"Wildburger NC, Hartke AS, Schidlitzki A, Richter F. Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms. Front Cell Dev Biol. 2020;8:598446. https:\/\/doi.org\/10.3389\/fcell.2020.598446.","DOI":"10.3389\/fcell.2020.598446"},{"issue":"2","key":"988_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41419-020-2285-7","volume":"11","author":"T Chakroun","year":"2020","unstructured":"Chakroun T, Evsyukov V, Nyk\u00e4nen NP, H\u00f6llerhage M, Schmidt A, Kamp F, et al. Alpha-synuclein fragments trigger distinct aggregation pathways. Cell Death Dis. 2020;11(2):84. https:\/\/doi.org\/10.1038\/s41419-020-2285-7.","journal-title":"Cell Death Dis"},{"issue":"2","key":"988_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2020;140(2):99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2.","journal-title":"Acta Neuropathol"},{"issue":"5\u20136","key":"988_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.phrs.2008.09.006","volume":"58","author":"KA Maguire-Zeiss","year":"2008","unstructured":"Maguire-Zeiss KA. alpha-Synuclein: a therapeutic target for Parkinson\u2019s disease? Pharmacol Res. 2008;58(5\u20136):271\u201380. https:\/\/doi.org\/10.1016\/j.phrs.2008.09.006.","journal-title":"Pharmacol Res"},{"issue":"33","key":"988_CR34","doi-asserted-by":"publisher","first-page":"14063","DOI":"10.1073\/pnas.0900096106","volume":"106","author":"H Jang","year":"2009","unstructured":"Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA. 2009;106(33):14063\u20138. https:\/\/doi.org\/10.1073\/pnas.0900096106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"988_CR35","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1007\/s00415-021-10444-6","volume":"268","author":"VA Blanco-Palmero","year":"2021","unstructured":"Blanco-Palmero VA, Azc\u00e1rate-D\u00edaz FJ, Ruiz-Ortiz M, Laespada-Garc\u00eda MI, R\u00e1bano-Su\u00e1rez P, M\u00e9ndez-Guerrero A, et al. Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms. J Neurol. 2021;268(9):3116\u201324. https:\/\/doi.org\/10.1007\/s00415-021-10444-6.","journal-title":"J Neurol"},{"issue":"12","key":"988_CR36","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1906466117","volume":"117","author":"R Marreiros","year":"2020","unstructured":"Marreiros R, M\u00fcller-Schiffmann A, Trossbach SV, Prikulis I, H\u00e4nsch S, Weidtkamp-Peters S, et al. Disruption of cellular proteostasis by H1N1 influenza A virus causes \u03b1-synuclein aggregation. Proc Natl Acad Sci USA. 2020;117(12):6741\u201351. https:\/\/doi.org\/10.1073\/pnas.1906466117.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"988_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J, L\u00fctgehetmann M, Hagel C, Sperhake JP, Schr\u00f6der AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919\u201329. https:\/\/doi.org\/10.1016\/s1474-4422(20)30308-2.","journal-title":"Lancet Neurol"},{"key":"988_CR38","doi-asserted-by":"publisher","unstructured":"Pedrosa C, Goto-Silva L, Temerozo JR, Souza LRQ, Vit\u00f3ria G, Ornelas IM et al. Non-permissive SARS-CoV-2 infection in human neurospheres. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2020.09.11.293951.","DOI":"10.1101\/2020.09.11.293951"},{"issue":"9","key":"988_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1474-4422(20)30269-6","volume":"19","author":"A Pavel","year":"2020","unstructured":"Pavel A, Murray DK, Stoessl AJ. COVID-19 and selective vulnerability to Parkinson\u2019s disease. Lancet Neurol. 2020;19(9):719. https:\/\/doi.org\/10.1016\/S1474-4422(20)30269-6.","journal-title":"Lancet Neurol"},{"issue":"1","key":"988_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","volume":"27","author":"L Yang","year":"2020","unstructured":"Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020;27(1):125-36.e7. https:\/\/doi.org\/10.1016\/j.stem.2020.06.015.","journal-title":"Cell Stem Cell"},{"issue":"22","key":"988_CR41","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acschemneuro.0c00676","volume":"11","author":"O Tavassoly","year":"2020","unstructured":"Tavassoly O, Safavi F, Tavassoly I. Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection. ACS Chem Neurosci. 2020;11(22):3704\u20136. https:\/\/doi.org\/10.1021\/acschemneuro.0c00676.","journal-title":"ACS Chem Neurosci"},{"issue":"7816","key":"988_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459\u201368. https:\/\/doi.org\/10.1038\/s41586-020-2286-9.","journal-title":"Nature"},{"issue":"5","key":"988_CR43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.28084","volume":"35","author":"A Lippi","year":"2020","unstructured":"Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: at the crossroad between aging and neurodegeneration. Movement Dis. 2020;35(5):716\u201320. https:\/\/doi.org\/10.1002\/mds.28084.","journal-title":"Movement Dis"},{"issue":"6","key":"988_CR44","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/jvi.02949-15","volume":"90","author":"EL Beatman","year":"2015","unstructured":"Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE, et al. Alpha-synuclein expression restricts RNA viral infections in the brain. J Virol. 2015;90(6):2767\u201382. https:\/\/doi.org\/10.1128\/jvi.02949-15.","journal-title":"J Virol"},{"issue":"5","key":"988_CR45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","volume":"9","author":"E Stolzenberg","year":"2017","unstructured":"Stolzenberg E, Berry D, Yang D, Lee EY, Kroemer A, Kaufman S, et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun. 2017;9(5):456\u201363. https:\/\/doi.org\/10.1159\/000477990.","journal-title":"J Innate Immun"},{"key":"988_CR46","doi-asserted-by":"publisher","unstructured":"Bantle CM, Phillips AT, Smeyne RJ, Rocha SM, Olson KE, Tjalkens RB. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation. npj Parkinson's Dis. 2019;5(1):20. https:\/\/doi.org\/10.1038\/s41531-019-0090-8.","DOI":"10.1038\/s41531-019-0090-8"},{"issue":"5","key":"988_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1159\/000479653","volume":"9","author":"V Labrie","year":"2017","unstructured":"Labrie V, Brundin P. Alpha-synuclein to the rescue: immune cell recruitment by alpha-synuclein during gastrointestinal infection. J Innate Immun. 2017;9(5):437\u201340. https:\/\/doi.org\/10.1159\/000479653.","journal-title":"J Innate Immun"},{"issue":"1","key":"988_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004;1(1):14. https:\/\/doi.org\/10.1186\/1742-2094-1-14.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"988_CR49","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/glia.20532","volume":"55","author":"W Zhang","year":"2007","unstructured":"Zhang W, Dallas S, Zhang D, Guo JP, Pang H, Wilson B, et al. Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia. 2007;55(11):1178\u201388. https:\/\/doi.org\/10.1002\/glia.20532.","journal-title":"Glia"},{"issue":"11","key":"988_CR50","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","volume":"29","author":"X Su","year":"2008","unstructured":"Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Synuclein activates microglia in a model of Parkinson\u2019s disease. Neurobiol Aging. 2008;29(11):1690\u2013701. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.04.006.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"988_CR51","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","volume":"182","author":"AD Reynolds","year":"2009","unstructured":"Reynolds AD, Stone DK, Mosley RL, Gendelman HE. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J Immunol. 2009;182(7):4137\u201349. https:\/\/doi.org\/10.4049\/jimmunol.0803982.","journal-title":"J Immunol"},{"issue":"1","key":"988_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbrc.2009.02.002","volume":"381","author":"SB Lee","year":"2009","unstructured":"Lee SB, Park SM, Ahn KJ, Chung KC, Paik SR, Kim J. Identification of the amino acid sequence motif of alpha-synuclein responsible for macrophage activation. Biochem Biophys Res Commun. 2009;381(1):39\u201343. https:\/\/doi.org\/10.1016\/j.bbrc.2009.02.002.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"988_CR53","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/039463200902200405","volume":"22","author":"H Wilms","year":"2009","unstructured":"Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Sch\u00e4fer H, Seegert D, et al. Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils. Int J Immunopathol Pharmacol. 2009;22(4):897\u2013909. https:\/\/doi.org\/10.1177\/039463200902200405.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"988_CR54","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s11064-011-0439-9","volume":"36","author":"SA Austin","year":"2011","unstructured":"Austin SA, Rojanathammanee L, Golovko MY, Murphy EJ, Combs CK. Lack of alpha-synuclein modulates microglial phenotype in vitro. Neurochem Res. 2011;36(6):994\u20131004. https:\/\/doi.org\/10.1007\/s11064-011-0439-9.","journal-title":"Neurochem Res"},{"issue":"41","key":"988_CR55","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1523\/jneurosci.1799-06.2006","volume":"26","author":"SA Austin","year":"2006","unstructured":"Austin SA, Floden AM, Murphy EJ, Combs CK. Alpha-synuclein expression modulates microglial activation phenotype. J Neurosci. 2006;26(41):10558\u201363. https:\/\/doi.org\/10.1523\/jneurosci.1799-06.2006.","journal-title":"J Neurosci"},{"issue":"11","key":"988_CR56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.imbio.2014.07.014","volume":"219","author":"W Xiao","year":"2014","unstructured":"Xiao W, Shameli A, Harding CV, Meyerson HJ, Maitta RW. Late stages of hematopoiesis and B cell lymphopoiesis are regulated by \u03b1-synuclein, a key player in Parkinson\u2019s disease. Immunobiology. 2014;219(11):836\u201344. https:\/\/doi.org\/10.1016\/j.imbio.2014.07.014.","journal-title":"Immunobiology"},{"issue":"1","key":"988_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/vim.2018.0075","volume":"32","author":"KE Lesteberg","year":"2019","unstructured":"Lesteberg KE, Beckham JD. Immunology of west nile virus infection and the role of alpha-synuclein as a viral restriction factor. Viral Immunol. 2019;32(1):38\u201347. https:\/\/doi.org\/10.1089\/vim.2018.0075.","journal-title":"Viral Immunol"},{"issue":"8","key":"988_CR58","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/mds.28185","volume":"35","author":"S Ait Wahmane","year":"2020","unstructured":"Ait Wahmane S, Achbani A, Ouhaz Z, Elatiqi M, Belmouden A, Nejmeddine M. The possible protective role of \u03b1-synuclein against severe acute respiratory syndrome coronavirus 2 infections in patients with parkinson\u2019s disease. Movement Dis. 2020;35(8):1293\u20134. https:\/\/doi.org\/10.1002\/mds.28185.","journal-title":"Movement Dis"},{"issue":"15","key":"988_CR59","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/jvi.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264\u201375. https:\/\/doi.org\/10.1128\/jvi.00737-08.","journal-title":"J Virol"},{"issue":"12","key":"988_CR60","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.tins.2020.10.009","volume":"43","author":"P Brundin","year":"2020","unstructured":"Brundin P, Nath A, Beckham JD. Is COVID-19 a perfect storm for Parkinson\u2019s disease? Trends Neurosci. 2020;43(12):931\u20133. https:\/\/doi.org\/10.1016\/j.tins.2020.10.009.","journal-title":"Trends Neurosci"},{"issue":"3","key":"988_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cns.13609","volume":"27","author":"F Iravanpour","year":"2021","unstructured":"Iravanpour F, Dargahi L, Rezaei M, Haghani M, Heidari R, Valian N, et al. Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of Parkinson\u2019s disease. CNS Neurosci Ther. 2021;27(3):308\u201319. https:\/\/doi.org\/10.1111\/cns.13609.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"988_CR62","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/ejn.12263","volume":"38","author":"K Obashi","year":"2013","unstructured":"Obashi K, Okabe S. Regulation of mitochondrial dynamics and distribution by synapse position and neuronal activity in the axon. Eur J Neurosci. 2013;38(3):2350\u201363. https:\/\/doi.org\/10.1111\/ejn.12263.","journal-title":"Eur J Neurosci"},{"key":"988_CR63","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ncb1907","volume":"11","author":"N Ishihara","year":"2009","unstructured":"Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki S, Masuda K, et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol. 2009;11:958\u201366. https:\/\/doi.org\/10.1038\/ncb1907.","journal-title":"Nat Cell Biol"},{"key":"988_CR64","doi-asserted-by":"publisher","unstructured":"Gao F, Reynolds MB, Passalacqua KD, Sexton JZ, Abuaita BH, O\u2019Riordan MXD. The Mitochondrial Fission Regulator DRP1 Controls Post-Transcriptional Regulation of TNF-\u03b1. Front Cell Infect Microbiol. 2021;10. https:\/\/doi.org\/10.3389\/fcimb.2020.593805.","DOI":"10.3389\/fcimb.2020.593805"},{"key":"988_CR65","doi-asserted-by":"publisher","unstructured":"Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH et al. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome. Journal of immunology (Baltimore, Md : 1950). 2014;193(6):3080\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1303196.","DOI":"10.4049\/jimmunol.1303196"},{"issue":"4","key":"988_CR66","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1073858420960443","volume":"27","author":"K Holder","year":"2021","unstructured":"Holder K, Reddy PH. The COVID-19 effect on the immune system and mitochondrial dynamics in diabetes, obesity, and dementia. Neuroscientist. 2021;27(4):331\u20139. https:\/\/doi.org\/10.1177\/1073858420960443.","journal-title":"Neuroscientist"},{"issue":"6","key":"988_CR67","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52(6):910\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.002.","journal-title":"Immunity"},{"key":"988_CR68","doi-asserted-by":"publisher","unstructured":"Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. https:\/\/doi.org\/10.1016\/j.clim.2020.108448.","DOI":"10.1016\/j.clim.2020.108448"},{"key":"988_CR69","doi-asserted-by":"publisher","unstructured":"Dutta A, Das A, Kondziella D, Stachowiak MK. Bioenergy Crisis in Coronavirus Diseases? Brain Sci. 2020;10(5). https:\/\/doi.org\/10.3390\/brainsci10050277.","DOI":"10.3390\/brainsci10050277"},{"issue":"48","key":"988_CR70","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1523\/jneurosci.2220-12.2012","volume":"32","author":"Y Nakata","year":"2012","unstructured":"Nakata Y, Yasuda T, Fukaya M, Yamamori S, Itakura M, Nihira T, et al. Accumulation of \u03b1-synuclein triggered by presynaptic dysfunction. J Neurosci. 2012;32(48):17186\u201396. https:\/\/doi.org\/10.1523\/jneurosci.2220-12.2012.","journal-title":"J Neurosci"},{"key":"988_CR71","doi-asserted-by":"publisher","unstructured":"Rahmati M, Fatemi R, Yon DK, Lee SW, Koyanagi A, Il Shin J et al. The effect of adherence to high-quality dietary pattern on COVID-19 outcomes: A systematic review and meta-analysis. J Med Virol. 2023;95(1):e28298. https:\/\/doi.org\/10.1002\/jmv.28298.","DOI":"10.1002\/jmv.28298"},{"key":"988_CR72","doi-asserted-by":"publisher","unstructured":"Rahmati M, Shamsi MM, Khoramipour K, Malakoutinia F, Woo W, Park S et al. Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis. Rev Med Virol. 2022;32(5):e2349. https:\/\/doi.org\/10.1002\/rmv.2349.","DOI":"10.1002\/rmv.2349"},{"issue":"2","key":"988_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.joim.2023.01.003","volume":"21","author":"M Rahmati","year":"2023","unstructured":"Rahmati M, Molanouri Shamsi M, Woo W, Koyanagi A, Won Lee S, Keon Yon D, et al. Effects of physical rehabilitation interventions in COVID-19 patients following discharge from hospital: A systematic review. J Integr Med. 2023;21(2):149\u201358. https:\/\/doi.org\/10.1016\/j.joim.2023.01.003.","journal-title":"J Integr Med"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-023-00988-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-023-00988-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-023-00988-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T16:58:15Z","timestamp":1730134695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-023-00988-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s13577-023-00988-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"15 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}